EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

Yoana Sotirova iD, Nadezhda Ivanova iD, Neli Ermenlieva, Neli Vilhelmova-Ilieva iD, Lora Simeonova iD, Miroslav Metodiev, Viliana Gugleva iD, Velichka Andonova iD

Pharmaceuticals · 04.03.2025 · 18 (3) · 366

DOI: 10.3390/ph18030366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.03.2025. Verfasst von Yoana Sotirova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 9000 Varna, Bulgaria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fund "Nauka" at the Medical University of Varna, Bulgaria, Fund “Nauka” at the Medical University of Varna, Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich Hypericum perforatum L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms.

Methods

Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 10031, and Candida albicans ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption.

Results

The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against S. aureus (MBC 6.3 mg/mL), K. pneumoniae (MBC 97.7 µg/mL), and C. albicans (MFC < 48.8 µg/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against E. coli, P. aeruginosa, the HSV-1 extracellular virions, or viral adhesion.

Conclusions

It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.

Schlagwörter

Stichwörter der Autor:innen

St. John’s wortantibacterial activityantifungal activityantimicrobial activityantiviral activityherpesvirushyperforinlipid nanoparticlesnanostructured lipid carriersphloroglucinols

Autor:innen und Institutionen

  • Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 9000 Varna, Bulgaria.
  • Department of Microbiology and Virology, Faculty of Medicine, Medical University of Varna, 9000 Varna, Bulgaria.
  • Department of Virology, Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 26 G. Bonchev Str., 1113 Sofia, Bulgaria.

ORCID-Profile: Yoana Sotirova, Nadezhda Ivanova, Neli Vilhelmova-Ilieva, Lora Simeonova, Viliana Gugleva, Velichka Andonova

Förderung

  • Fund "Nauka" at the Medical University of Varna, Bulgaria
  • Fund “Nauka” at the Medical University of Varna, Bulgaria

Zitieren

APA

Sotirova, Y., Ivanova, N., Ermenlieva, N., Vilhelmova-Ilieva, N., Simeonova, L., Metodiev, M., Gugleva, V., & Andonova, V. (2025). Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract. Pharmaceuticals, 18(3), 366. https://doi.org/10.3390/ph18030366

Vancouver

Sotirova Y, Ivanova N, Ermenlieva N, Vilhelmova-Ilieva N, Simeonova L, Metodiev M, et al. Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract. Pharmaceuticals. 2025;18(3):366. doi:10.3390/ph18030366

BibTeX
@article{Sotirova2025,
  author = {Sotirova, Yoana and Ivanova, Nadezhda and Ermenlieva, Neli and Vilhelmova-Ilieva, Neli and Simeonova, Lora and Metodiev, Miroslav and Gugleva, Viliana and Andonova, Velichka},
  title = {Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {3},
  pages = {366},
  doi = {10.3390/ph18030366}
}
Kostenlos starten →